DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
New York Senate Bill 1839 and Assembly Bill 6430—Sickle Cell Disease Detection and Education Program
Hello Partners in Advocacy!
The Sickle Cell/Thalassemia Patients Network (SCTPN) on behalf of all of the other sickle cell disease (SCD) community organizations are circulating a letter to the Chairs of the Assembly and Senate Health Committees for support of the Sickle Cell Disease Education and Detection bill S1839.
The letter requests that the state leaders dedicate $750,000 to educating health professionals and the public about sickle cell trait and disease. It will also provide funding to community-based organizations in the Fiscal Year 2023-24 to expand public outreach and education efforts.
SCTPN are inviting organizations who care about rare and chronic diseases and improving the quality of life for those who are impacted to sign on to the letter linked below.
If your organization supports the Senate Bill S1839 (Sanders), email “Yes, I Support” to Ginger Davis [email protected] or Ashley Thompkins at [email protected].
Organization and Individual names will be listed on the letter. Please email your organization logo to include with the letter.
Related Content
-
news & eventsMARAC Advisory Statement: Monoclonal Antibodies Against SARS-CoV-2August 26, 2021 – The Sickle Cell Dis...
-
education & researchEarly occurrence of red blood cell alloimmunization in patients with sickle cell diseaseRed blood cell (RBC) alloimmunization is...
-
people & placesChildren’s Hospital of PittsburghChildren’s Hospital of Pittsburgh of U...
-
news & eventsWebinar Series: Sickle Cell Science: Path to Progress – Sickle Cell Disease Care in the Emergency Department: ...To commemorate Sickle Cell Awareness Mon...
-
education & researchRandomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased ...Treatment of vaso-occlusive crises (VOC)...
-
Community CenterToday’s Faces of Sickle Cell Disease: Tesha SamuelsTesha Samuels was diagnosed with SCD at ...
-
people & placesAlecia Nero, MDA hematology specialist at UT Southweste...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.